The Network Science Institute, home of the nation’s first doctoral program in network science, brings together an interdisciplinary team of renowned Northeastern scholars to plumb the structure and function of systems and develop intervention strategies to improve the health and security of people around the world.
Thirty students took part in NU-CD4. The course focused on the drug development process and gave the students the opportunity both to visit world-leading institutions in pharmaceutical research and manufacturing and conduct a research project focusing on identifying problems with existing drugs and developing novel remedies for those problems.
Maggy Benson, S’06, might not have become the face of a popular television-style program at the Smithsonian’s National Museum of Natural History had it not been for Northeastern’s co-op program.
For the members of the Mixed Paper Design Collaborative, founded by four Northeastern alumni, addressing global climate change will be the name of the game on Saturday afternoon in Boston.
If you want to ace your exams, you’ll need to study hard. But, says Fred Davis, a biology professor with expertise in circadian rhythms, you’ll also need to put down the books and catch a little shuteye.
Professor Matthias Mann, Director in the Department of Proteomics and Signal Transduction at the Max Planck Institute of Biochemistry in Munich, Germany, was the recipient the Inaugural Barry L. Karger Medal in Bioanalysis.
Adversity makes you more compassionate. Except when others are suffering as you did.
Meet Kathleen Lotterhos, a new assistant professor who joined Northeastern this fall. At Northeastern’s Marine Science Center, she will continue her exciting research uncovering clues to environmental sustainability by using genetic analyses to study species from pine trees to Pacific rockfish.
Phillip Strandwitz wants to raise $50,000 to help research whether bacteria in our guts play a role in depression and anxiety.
James Aggen, a professor in the College of Science and Bouve College of Health Sciences, describes his to work to develop antidotes for multidrug-resistant (MDR) Gram-negative bacterial infections.